Summit Wealth & Retirement Planning’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Summit Wealth & Retirement Planning's LLY Position: Q1 2026 in Review
Summit Wealth & Retirement Planning increased its Eli Lilly (LLY) stake by 23% in Q1 2026, buying an estimated $241K and bringing the position to 1,260 shares worth $1.16M. The position accounts for 0.28% of the portfolio, ranked #39.
Summit Wealth & Retirement Planning first reported a position in LLY in Q4 2018 and has held it in 12 quarters since. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Summit Wealth & Retirement Planning held 1,260 shares of Eli Lilly worth $1.16M as of Q1 2026.
- Summit Wealth & Retirement Planning bought 238 Eli Lilly shares in Q1 2026, an estimated $241K.
- Eli Lilly made up 0.28% of Summit Wealth & Retirement Planning's portfolio in Q1 2026, its #39 holding.
- Summit Wealth & Retirement Planning first reported a position in Eli Lilly in Q4 2018 and has held it in 12 quarters since.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Summit Wealth & Retirement Planning's 13F filing for Q1 2026, filed 11 May 2026.